Try our Advanced Search for more refined results
Life Sciences - December, 2020
284 articles
- The Most-Read Legal Industry Guests Of 2020
- How 2020 Changed The Way Companies Go Public
- Arthrex Tells Justices To End IPRs, Kick PTAB To Congress
- Trump's 'Most-Favored Nation' Rule On Drug Prices Blocked
- SEC Urges Blank-Check Companies To Bolster Disclosures
- AbbVie Tells 7th Circ. Asserting Rights Isn't 'Patent Thicket'
- Top 5 Gov't Contracts Of 2020: Year In Review
- A Look At Trademark Law Changes In Congress' Spending Bill
- Storage Tank Co. Wants Out Of Embryo Class Action
- Real Estate Rumors: Comparato, Square Mile, Related
- Zimmer Angles To Knock Out Bias Suit Over Severance
- Canopy Slaps GW With Patent Suit Over Flagship CBD Drug
- A Law Firm's Guide To Producing A Podcast
- UK Litigation Roundup: Here's What You Missed In London
- Trump Assails $900B COVID-19 Relief Bill In Twitter Video
- 5 Highlights As DOJ Depicts Walmart As Opioid Crisis Villain
- Investors Slam Inovio's Bid To Duck COVID-19 Vaccine Suit
- Shkreli Can't Delay January FTC Deposition, NY Judge Says
- PhRMA Urges Full Fed. Circ. To Walk Back New Venue Limits
- Columbia Care To Acquire Green Leaf Medical For $240M
- Late-Night Relief Bill Will Spur Big Changes To IP
- Okla. Says Pot Residency Rules Can't Be Unconstitutional
- Del. Judge Nixes Equity Panel For 'Insolvent' Mallinckrodt PLC
- Pot Co. Wants Ex-Worker, Attys Sanctioned For 'Fruitless' Suit
- 2 Major Digital Health Trends Driven By COVID-19
- What Gov't Contracting Might Look Like Under Biden
- DOJ Sues Walmart Over Opioid Crisis
- 11th Circ. Backs Bayer In Birth Control Stroke Suit
- Eli Lilly Beats Generic Cancer Drug Again At Fed. Circ.
- Cannabis Co. Ayr Enters Fla., NJ With Deals Totaling $391M
- Coronavirus Regulations: A State-By-State Week In Review
- Willkie, Skadden Steer $1.3B PE Sale Of Sparta To Honeywell
- 5 Important E-Discovery Trends And Developments In 2020
- Congress Backs $900B COVID-19 Relief, Gov't Spending Bill
- CORRECTED: Sacklers Saw Litigation Threat As Early As 2007, Creditors Say
- Jury Clears Drug Wholesaler Over Dubious Int'l Shipment
- 16 New Blank-Check Co. IPO Filings Bolster 2021 Pipeline
- EEOC Inks $175K Pact With Pot Retailer In Harassment Case
- Pfizer's COVID-19 Vaccine Wins Race For EU Approval
- Senate Passes Bill To Levy Economic Sanctions For IP Theft
- Missouri's Pot License Cap Kept Intact As Challenge Fizzles
- Biomet Asks Judge To Ax $21M Hip Implant Verdict
- Baker McKenzie, Wachtell Guide Servier's $2B Cancer Biz Buy
- NJ Water Supplier Wants DuPont, Chemours To Fund Cleanup
- Ex-Theranos CEO's Fraud Trial Moved To July Due To Virus
- 2nd Circ. Won't Rehear Suit Over $600M NY Opioid Tax Law
- Ventilator Co. Strikes $40.5M Deal To End Feds' Fraud Suit
- Judges On Race: The Path To A More Diverse Bench
- DEA Issues Rule To Boost Research Cannabis Cultivation
- Bayer, MSN Labs Seek To Drop Drug IP Fight Midtrial
- No Preemption In Blood Pressure Drug Contamination MDL
- Biotech CEO Charged With Pushing Fake Fast COVID-19 Test
- Goodwin-Led Lab Device Maker's Shares Soar In $130M IPO
- 3rd Circ. Seeks NJ High Court Input In Pelvic Mesh Fees Fight
- 1st Circ. Backs Biogen's Win In Scientist's Disability Bias Suit
- FDA Approves Moderna COVID-19 Vaccine For Emergency Use
- Insurer Lost Millions In Regeneron Drug Scheme, Suit Says
- Calif. Opioid Judge Wary Of Atty Burnout Amid Pandemic
- Compulsory Licensing To Cut Drug Costs Could Harm Public
- Initial Census, Data Analytics Can Aid MDL Management
- A Look At Contrasting Rules For Excess Insurance Policies
- Taxation With Representation: Freshfields, Wachtell, Simpson
- S&C, Greenberg Drive $2.8B Deal For Medical Device Co.
- Full Fed. Circ. Won't Take Up Biogen Appeal Over MS Drug
- Pfizer Faces 1st Damages Trial In 2021 Over Axed Lyrica IP
- 5 Big Developments That Shaped The PTAB In 2020
- 'Killer' Deals, Internet Mergers Caught Enforcers' Eyes In 2020
- Fed. Circ. Won't Revive Patent Suit Over Gallbladder Drug
- FDA Panel Backs Moderna's COVID-19 Vaccine
- Facing Congress' Ire, Sacklers Deflect Blame For Opioid Crisis
- SEC Says Biotech Co. Duped Investors Over COVID-19 Tests
- Monsanto, BASF Plan Appeal Of $75M Dicamba Ruling
- EpiPen Trial Not Feasible Nor Prudent Amid Virus, Judge Says
- Ohio Justices Take Up Acuity's Opioid Suit Coverage Fight
- Year In Review: How Cannabis Law Fared In 2020
- Ex-Indivior Exec Dodges Prison In Suboxone Opioid Case
- J&J Hit With Workplace Bias Suit By Fired Female Exec
- How New Kickback Rules Benefit Health Care Industry: Part 2
- Gilead Says Overbroad Patent Doesn't Need Justices' Review
- Priest Seems Destined For Trial In SEC Short-Selling Suit
- Novartis To Buy Neuroscience Therapy Biz For Up To $770M
- Blackstone's Investment Values Software Co. Over $2B
- Biogen To Pay $22M To Resolve Drug Kickback Claims
- Red White & Bloom Borrows $60M, Buys Ill. Pot Grow Assets
- The 10 Biggest Patent Rulings Of 2020
- Top 10 Whistleblowing And Retaliation Events Of 2020
- ITC Orders Import Ban For Botox Rival In Trade Secrets Case
- Generics 'Urgently' Call On Fed. Circ. To Protect Skinny Labels
- Fintech Lender, Biotech Startup Price IPOs Totaling $429M
- Mallinckrodt Says Market Bodes Ill For Ch. 11 Equity Salvage
- Bausch Accuses Lupin Of Infringing Plenvu Patents
- Express Scripts Says Bad Jury Instructions Led To $82M Loss
- Ex-Theranos CEO, Feds Spar Over Atty-Client Privilege
- How New Kickback Rules Benefit Health Care Industry: Part 1
- The Top Product Liability Cases Of 2020
- Eli Lilly Should Face IP Suit Over Migraine App, Judge Says
- US Attorney In Ohio To Step Down In January
- J&J Elmiron Suits Sent To NJ Federal Court
- FDA, USPTO Data Show Earlier Small-Molecule Drug Patenting
- Feds Say Hospital Illegally Made Nurses Help With Abortions
- Sanofi Asks 5th Circ. To Toss Chemo Drug Hair Loss Claims
- Senate OKs Bill To Expand Research On Medical Cannabis
- COVID-19 Has Broad Impact On Lost-Profit Determinations
- After A Year's Wait, Fed. Circ. Simply OKs Biogen's PTAB Loss
- Quest Wants 'Threadbare' ERISA Class Action Tossed
- Tips For Identifying A Culturally Competent Mediator
- Mallinckrodt Stockholders Face Slim Chance Of Ch. 11 Payout
- Judge Allows Bio-Rad To Collect $35M IP Judgment
- DOJ Opioid Leader Flays Pharmacies In Enforcement Vow
- Zantac MDL Defendants Argue Claims Are Preempted
- Juno Tells Fed. Circ. To Uphold Its $1.2B Patent Win Over Kite
- 3rd Circ. Doubts Par's Exclusive Deal Is Anti-Competitive
- Prepare For More Electronic Device Searches At US Borders
- Coronavirus Regulations: A State-By-State Week In Review
- Trump's 'Most-Favored Nation' Rule Faces More Lawsuits
- A Look At Spoliation Risk In The 11th Circ., By The Numbers
- Mylan Tries To Escape Pharmacy's EpiPen Antitrust Suit
- Mapping The Contours Of PTAB Discretionary Denials In 2020
- 3 Firms Guide $1B Lilly Deal For ALS Drug Researcher
- Pa. Sanofi Workers Sue Over Unkept Hazard Pay Pledge
- Del. Justices Affirm Chemours-DuPont Arbitration Ruling
- Lloyd's, Tech Co. Launch Virus Vaccine Transport Cover
- Baker Botts Scores IP Partner From Sidley Austin In Calif.
- Mallinckrodt's Ch. 11 Fee Payout Proposal Rejected
- Karyopharm Execs Hit With Investor Suit Over Cancer Drug
- Drugmakers Call Zantac MDL 'Shotgun Pleadings'
- DLA Piper-Led Gene Therapy Co. Scores $100M In Funding
- Walgreens Goes After Generic Cos. Over Alleged Price-Fixing
- Biotech's Former Brass Fights SEC Efforts To Get Court Wins
- J&J Prevails In Tenn. Woman's Pelvic Mesh Suit At 6th Circ.
- Insurer Wants No Part Of $20M Judgment In Akorn Meds Suit
- E-Commerce Giant Wish To Lead 11 IPOs In Year's Final Rush
- 2 Sacklers To Testify On Purdue's Role In Opioid Crisis
- Facebook, BigLaw Attys Discuss Increasing Diversity In IP
- Justices Won't Review Cochlear's $268M Hearing Aid IP Loss
- Medical Pot Exec Sues Missouri Over License Residency Rule
- High Court Passes On Atty's Stock Fraud Appeal, Again
- Simpson, Skadden Build $3.45B Deal For Lab Office Portfolio
- Freshfields, Wachtell Drive $39B AstraZeneca-Alexion Deal
- Millions Of Health Care Workers Set To Get COVID-19 Vaccine
- Allergan Must Face FCA Claims Over Dementia Drug Patents
- Del. Chief Urges Creativity When Litigating Patent Eligibility
- Judges Stoll, Albright Dish On Litigating During COVID-19
- Chinese National Admits Stealing Lab Trade Secrets With Wife
- Senate Passes Bills On Drug Patent Listings
- IP Owners Have Usually Found Ally In Trump Administration
- A Closer Look At High Court Schein Carveout Case Arguments
- Insurer Can't Yet Dodge Defending Surgical Co. In J&J Suit
- RJ Reynolds Says FDA Cigarette Warnings Flout Free Speech
- Foley Hoag Lures Trade Secret Pro To Lead NY Employment Team
- Misguided Sensipar Ruling Threatens Patent Settlements
- Risks In Moving Too Quickly, Or Slowly, On COVID-19 Vaccine
- Celgene, Cipla Resolve Patent Claims Over Cancer Drug
- No Need To Explain Strategy In Doc Demand, Del. Justices Say
- Fast COVID-19 Vaccines Raise Call For More Collaboration
- AbbVie As Both Victim And Villain Dooms Kickback Suit
- SC Republicans File Medical Marijuana Legalization Bills
- 1st Circ. OKs $763K Retaliation Verdict Against Coloplast
- 10X Calls Fraud In Latest Effort To Dodge $24M Jury Verdict
- Judge Awards Attys $6M In Fees In Intuniv Antitrust Suit
- Coronavirus Litigation: The Week In Review
- Fed. Circ. Again Says No State Sovereign Immunity In IPRs
- Still No WTO Agreement On COVID-19 IP Waiver
- Fed. Claims Judge Tosses Okla. Tribe's 'Bad Men' Opioid Suit
- FDA Panel Backs Emergency Use For Pfizer COVID-19 Vaccine
- Deals Rumor Mill: Robinhood, ChemChina, Omnicell
- HHS Working Group Could Take FCA Pressure Off Health Cos.
- Opioid Committee Wants Claim Deadline In Mallinckrodt Ch. 11
- Life Sciences Group Of The Year: Gibson Dunn
- 4 Firms Steer Gilead's €1.45B Deal For Germany's MYR
- High Court Gives States Green Light To Regulate PBMs
- 9th Circ. Revives ACA Claims Over Access To CVS HIV Drugs
- Ex-Nanotech CEO Accused Of $12.2M Securities Fraud Scam
- Mallinckrodt Opioid Claimants Want OK For Info Website
- Perrigo Must Share Atty Advice Over $2B Tax Bill, Court Rules
- Hagens Berman To Lead Investors' COVID-19 Vaccine Suit
- Generics Partner Tells Justices It Can Appeal PTAB Ruling
- Roche Calls Meso's Bouchard-Related Bias Claims 'Weak'
- Fed. Circ. Judge Skeptical Amgen Cholesterol Drug IP Is Valid
- Startup Artio Medical Nabs New GC From Pet Pharma Co.
- HHS Alert Is Pharma's Guide To Mitigating Anti-Kickback Risk
- COVID-19 Spurs Associates To Think Bigger — Like Partners
- Life Sciences Group Of The Year: Dechert
- Argentinian Polo Star Sues Company Cloning His Horses
- House Approves Medical Marijuana Research Bill
- Zoll Medical Can't Escape Defibrillator Defect Death Suit
- Canada Backs Pfizer Virus Vaccine, Day Before FDA Meeting
- Endobotics Wins $192M In IP Dispute Over Surgical Device
- Pfizer, BioNTech Vaccine Docs Exposed In EU Regulator Hack
- Faruqi & Faruqi Replaces Pomerantz In Allergan Suit
- AbbVie Wants Allergan Merger Docs Out Of Opioid MDL
- Fed. Circ. Mulls Undoing Mylan Win In Biogen Drug IP Fight
- Oklahoma Backs $465M Opioid Win Against J&J
- Objector Challenges Bernstein Litowitz's $11M Fee At 7th Circ.
- Dental Co. Faces Scrutiny From High Court In Carveout Case
- City Tells Miss. Justices To Invalidate Medical Pot Measure
- Par Sues Generic Cos. Over Blood Pressure Drug
- Life Sciences Group Of The Year: Covington
- Coronavirus Regulations: A State-By-State Week In Review
- Congress Should Restore Coarse Filter For Patent Eligibility
- 2nd Circ. Tosses Claims Over Bayer's Mirena Implant
- GCs Are Uniquely Qualified To Lead Diversity Initiatives
- Big Pharma Slams 'Most-Favored Nation' Rule On Drug Prices
- Ex-Theranos CEO Claims Doc Privilege Via Boies Schiller
- Feds Ask 1st Circ. To Reinstate Full Insys Kickback Verdict
- Full Fed. Circ. Urged To Undo Hatch-Waxman Venue Limits
- Feds Call Walmart Preemptive Opioid Suit Improper
- COVID-19 Vaccines Unlikely To Create Litigation Opportunities
- Life Sciences Group Of The Year: Cohen Milstein
- 3 Ways Defendants Can Nip Civil RICO Claims In The Bud
- Another Opioid Bellwether Delayed For COVID-19
- NJ Justices Clear J&J Of Taxes On Coverage Beyond State
- Calif. AG Becerra Selected To Head HHS In Biden Era
- EU Clears DIC's €985M Deal For BASF Pigment Unit With Fix
- Pfizer Unit Gets 'Put Up' Order In Osteoarthritis IP Fight
- 2020's Top Pa. Employment Law Changes, And What's Ahead
- 2nd Circ. Backs Anthem, Express Scripts ERISA Victory
- Biden To Pick Calif. AG Xavier Becerra To Head HHS
- Judges On Race: Reducing Implicit Bias In Courtrooms
- Sens. Back PTAB Denial Rules, Drug Pricing Activists Balk
- Mylan Rival Can Sleep Easy On Insomnia Drug Patent
- FTC Says Likely Pay-For-Delay Deals Remain Few
- Ind. Panel Affirms Medtronic's $112M Loss In IP Contract Row
- 'Lifesaving' Claim Barred In Hernia Mesh Bellwether Trial
- Regeneron Can't Escape Feds' Medicare Kickback Case
- What Health Attys Are Bracing For As Virus Rages Nationwide
- Drug Co. Ex-CEO Liable For $1M FBAR Penalty
- 3rd Circ. Won't Rethink Nixing $448M AbbVie Penalty
- Former Exec Says Zimmer Had 'Figurative Gun To Her Head'
- 3 Biotech Cos. Raise $543M In Upsized Nasdaq Debuts
- California's Cannabis Delivery Law Is Clearer Than It Seems
- Life Sciences Group Of The Year: Arnold & Porter
- UK Litigation Roundup: Here's What You Missed In London
- Justices Warned Of 'Chaos' If They Dismantle AIA Reviews
- Patent Office Loses Stay Bid In PTAB Denials Challenge
- JPML Urged To Ship Elmiron Eye Damage Suits To NJ
- DHS, IBM Warn Of Phishing Bids Targeting Vaccine Delivery
- After Ballot Wins, Pot Faces Long Road To Launch In 5 States
- W.Va. Opioid Bellwether Delayed By Virus Concerns
- Female Judge Should Hear IUD Cases, JPML Told
- SEC Nets $9.8M From AWOL Sanofi Insider Trading Suspect
- DOJ Backs SmileDirect's Calif. Dental Board Case At 9th Circ.
- Vivus Cleared For Amended Ch. 11 Plan With Drug Royalties
- Minn. City Has Right To Ban Flavored Cigs, 8th Circ. Told
- Dueling Attys Call For Xyrem MDL To Be Moved To CA Or NJ
- DEA Faces Another Suit Over Stalled Pot Research
- Siemens, Former Employee Put End To Trade Secret Row
- Next Steps For Now-Legal Mississippi Medical Marijuana
- Navigating Atty Relationship Conflicts That May Imperil Cases
- Tech Titans Fight USPTO's Stay Bid In PTAB Denials Suit
- Ex-Insys Manager Avoids Prison For Opioid Kickback Scheme
- Don't Let Virus Delay W.Va. Opioid Bellwether, Court Urged
- Teva Says Fed. Circ. Made Skinny Label Law 'A Dead Letter'
- Bill To Boot Chinese Cos. From US Exchanges Sent To Trump
- Abbott Can't Escape Infringement Claims Over HIV Testing
- Biopharm Biz Buries Hatchet Over Parkinson's Drug For $7.5M
- Theranos Judge Says Virus Won't Delay Ex-CEO's March Trial
- Fla. Pharmacy Gets Chance To Prove Case Against McKesson
- Bernstein Litowitz Attys Fight Sanctions Bid In Stericycle Case
- Bad Jury Instructions Tainted Med Mal Trial, Pa. Justices Told
- DuPont Rips Chemours' 'Strange' Bid To Void Chancery Ruling
- JLL Guides Sidra's $225M Recapitalization Of Pa. Campus
- Del. Judge Keeps Alive Stanford IP Suits Over Kidney Test
- 2020 Election May Mark A Turning Point For Marijuana Law
- 5 Tips For Responding To Alice Patent Eligibility Rejections
- How Mediators Can Help Parties Overcome Emotional Barriers
- UK Backs Pfizer's Virus Vaccine As US Decision Looms
- In Opioid MDL, Fears Of Allergan Dissolving To Avoid Payout
- Del. Judge Finds Teva Infringed ADHD Drug IP On Remand
- GAO Rips Trump Admin. On COVID-19 Testing, Vaccine Plan
- Biosimilars Group Pushes For Medicine Access Measures
- DC Circ. Upholds FDA Rule Treating Vaping Like Tobacco
- Polsinelli Adds 2 Patent Pros To Miami Office
- Clinics Barred From Gilead HIV Drug Program For Now
- Shearman-Led Medical Device Co. Inks $800M Drug Biz Sale
- Coronavirus Regulations: A State-By-State Week In Review
- OB/GYN Says Immunity Won't Fly In Tribal Hospital Firing Suit
- NJ Justices Doubt Medical Pot Reimbursement Is Illegal
- High Court May Clarify Key Arbitration Issue
- High Court Could Expand FCA Reach In Resolving Circuit Split
- Moderna, Pfizer Playing The Long Game With Novel Vaccine IP
- Generic Co. Gets Horizon's Painkiller Patent Partly Axed
- Biotech Co. Says Rival Stole Trade Secrets In 'Brazen Fraud'
- Judging A Book: Wardlaw Reviews 'Hamilton And The Law'